Zenas BioPharma, Inc. (ZBIO – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...

Should you invest in Bicara Therapeutics Inc? Click for more on BCAX's promising cancer treatment, but proceed with caution ...

Positive 270-day Interim Clinical Study Data for the First Subject and Positive 180-day Interim Clinical Study Data for the Second Subject ...

水系电池由于具备本质安全、低成本、环保的特点，有望在未来大规模储能中实现应用，但是水系电池固有的瓶颈——负极界面的析氢问题严重限制了水系电池的寿命。电解质界面中间相（SEI）可以从动力学上抑制析氢反应，而传统的阴离子还原形成SEI高度依赖于高浓度的有 ...

Neighbours rally around 10-month-old boy with rare — and terminal — genetic disease Residents who live in Country Lane Estates trailer park south of Calgary helping raise money for family of a ...

Biopharma developer Kesmalea appoints Robert Johnson as CEO to lead development of pipeline focused on oral, CNS penetrant ...

(H) The change of the CD4+ T/ CD8+ T ratio. Pattern to illustrate the proof-of-concept strategy based on a bifunctional HSV-vectored therapeutic vaccine for HIV functional cure. In the present study, ...

INDIGO is the largest clinical trial conducted in patients living with IgG4-RD- -Topline INDIGO results expected by the end ...

Taken together, these findings demonstrated that our modified HSV-ΔICP34.5-based constructs potentially reactivated HIV/SIV latency by modulating the IKKα/β-NF-κB pathway and PP1-HSF1 pathway, and ...

IL-18 plays a key role in regulating innate immune responses, affecting natural killer cells, monocytes and other cell types.

Concluded targeted enrollment of Phase 3 INDIGO trial evaluating obexelimab for the treatment of Immunoglobulin G4-Related ...

Department of Chemistry, The University of Chicago, Chicago, Illinois 60637, United States ...